These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


301 related items for PubMed ID: 8913919

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients.
    Koelman CA, Vaessen LM, Balk AH, Weimar W, Doxiadis II, Claas FH.
    Transpl Immunol; 2000 Mar; 8(1):57-64. PubMed ID: 10834611
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Increased concentration of soluble human leukocyte antigen class I levels in the bronchoalveolar lavage of human pulmonary allografts.
    Rizzo M, Sundaresan S, Lynch J, Trulock EP, Cooper J, Patterson GA, Mohanakumar T.
    J Heart Lung Transplant; 1997 Nov; 16(11):1135-40. PubMed ID: 9402513
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM, Ismail AM, Sheashaa HA, Gheith OA, Kamal MM, Ghoneim MA.
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
    Webber SA, Bentlejewski C, Park A, Fricker FJ, Griffith C, Boyle GJ, Miller SA, Pham S, Murali S, Griffith BP, Duquesnoy R, Zeevi A.
    Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
    [Abstract] [Full Text] [Related]

  • 31. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM, Ozawa M, Verbanac KM, Catrou P, Haisch CE, Terasaki PI.
    Clin Transpl; 2006 Aug; ():241-53. PubMed ID: 18365382
    [Abstract] [Full Text] [Related]

  • 32. Quantitation of cytomegalovirus infection-associated histologic findings in endomyocardial biopsies of heart allografts.
    Koskinen PK, Krogerus LA, Nieminen MS, Mattila SP, Häyry PJ, Lautenschlager IT.
    J Heart Lung Transplant; 1993 Aug; 12(3):343-54. PubMed ID: 8392371
    [Abstract] [Full Text] [Related]

  • 33. Reliability and usefulness of immunofluorescence in heart transplantation.
    Bonnaud EN, Lewis NP, Masek MA, Billingham ME.
    J Heart Lung Transplant; 1995 Aug; 14(1 Pt 1):163-71. PubMed ID: 7727465
    [Abstract] [Full Text] [Related]

  • 34. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM, Steinmüller C, Wagner TO, Bruggeman CA, Haverich A, Steinhoff G.
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [Abstract] [Full Text] [Related]

  • 35. The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantation.
    van Emmerik NE, Loonen EH, Vaessen LM, Balk AH, Mochtar B, Claas FH, Weimar W.
    J Heart Lung Transplant; 1997 Feb; 16(2):240-9. PubMed ID: 9059936
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Endomyocardial biopsy in the heart transplant patient: the state of the art].
    Arbustini E, Grasso M, Diegoli M, Gavazzi A, Campana C, Martinelli L, Goggi C, Pucci A, Grossi P, Ippoliti G.
    G Ital Cardiol; 1991 Oct; 21(10):1107-23. PubMed ID: 1804749
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients.
    McMillan RW, Gelder FB, Zibari GB, Aultman DF, Adamashvili I, McDonald JC.
    Clin Transplant; 1997 Apr; 11(2):98-103. PubMed ID: 9113444
    [Abstract] [Full Text] [Related]

  • 40. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection.
    Reinsmoen NL, Cornett KM, Kloehn R, Burnette AD, McHugh L, Flewellen BK, Matas A, Savik K.
    Transplantation; 2008 Feb 15; 85(3):462-70. PubMed ID: 18301338
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.